ImproveR International (BI-001-IM)
Nycomed · Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)
Not applicable
Completed
4,000
2012-05
Industry sponsor intelligence
Lead-sponsor view of Nycomed's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
Pipeline overview
Velocity
Study start year · indexed snapshot
Development
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Teduglutide → | 2 | 2 | 0 | 0 | 0 | 0 |
| Bivalirudin → | 2 | 0 | 0 | 0 | 0 | 0 |
Active peptide trials
Completed trials
Nycomed · Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)
Not applicable
Completed
4,000
2012-05
Nycomed · Renal Impairment
Phase 1
Completed
36
2012-05
Nycomed · Healthy
Phase 1
Completed
72
2012-05
Search sponsor records
This page groups studies where Nycomed is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
4 matching studies
Last registry update first
Recent updates